ArticlePloS one2017

Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway.

Minyong Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.